T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
NCR Voyix
VYX
$1.17B
| $45.4M | ﹤0.01% |
1,909,256
-10,534
| -0.5% | -$274K |
|
1052
Nasdaq
NDAQ
$54.6B
| $45.4M | ﹤0.01% |
705,096
+7,284
| +1% | +$458K |
|
1053
Prosperity Bancshares
PB
$8.97B
| $45.3M | ﹤0.01% |
637,408
-1,104,033
| -63% | -$76.4M |
|
1054
Factset
FDS
$10.2B
| $45.2M | ﹤0.01% |
114,465
+1,184
| +1% | +$430K |
|
1055
Valero Energy
VLO
$98.7B
| $45M | ﹤0.01% |
637,498
-12,640
| -2% | -$841K |
|
1056
ACI Worldwide
ACIW
$5.42B
| $44.8M | ﹤0.01% |
1,457,577
-169,968
| -10% | -$5.64M |
|
|
BSKYU
1057
DELISTED
Big Sky Growth Partners, Inc. Unit
BSKYU
| $44.8M | ﹤0.01% |
4,486,156
| – | – |
|
|
PRFT
1058
DELISTED
Perficient Inc
PRFT
| $44.6M | ﹤0.01% |
385,751
+260,966
| +209% | +$26.8M |
|
|
CPAAU
1059
DELISTED
Conyers Park III Acquisition Corp. Unit
CPAAU
| $44.4M | ﹤0.01% |
+4,397,191
| New | +$44.1M |
|
1060
Fabrinet
FN
$20.3B
| $44.3M | ﹤0.01% |
432,515
-1,861
| -0.4% | -$182K |
|
1061
Pegasystems
PEGA
$5.51B
| $44.3M | ﹤0.01% |
696,406
-62,036
| -8% | -$4.13M |
|
1062
The RealReal
REAL
$1.33B
| $44.2M | ﹤0.01% |
3,354,704
+219,774
| +7% | +$3.26M |
|
1063
Kroger
KR
$35.1B
| $44.1M | ﹤0.01% |
1,089,996
-137,822
| -11% | -$5.79M |
|
|
CHCT
1064
Community Healthcare Trust
CHCT
$433M
| $44M | ﹤0.01% |
973,655
+5,589
| +0.6% | +$271K |
|
1065
Expeditors International
EXPD
$24.3B
| $44M | ﹤0.01% |
369,303
+7,494
| +2% | +$938K |
|
1066
Blackstone
BX
$112B
| $43.9M | ﹤0.01% |
377,754
-23,045
| -6% | -$2.67M |
|
1067
Bally's
BALY
$660M
| $43.8M | ﹤0.01% |
873,222
-268,968
| -24% | -$13.1M |
|
1068
Clorox
CLX
$12.9B
| $43.6M | ﹤0.01% |
263,116
-26,069
| -9% | -$4.49M |
|
1069
Albany International
AIN
$1.82B
| $43.2M | ﹤0.01% |
561,845
-67,891
| -11% | -$5.45M |
|
1070
Advanced Energy
AEIS
$13.2B
| $43.2M | ﹤0.01% |
491,859
-90,346
| -16% | -$8.45M |
|
1071
D.R. Horton
DHI
$41.9B
| $42.9M | ﹤0.01% |
511,247
-5,866
| -1% | -$540K |
|
1072
Comfort Systems
FIX
$60.8B
| $42.9M | ﹤0.01% |
601,032
-46,014
| -7% | -$3.43M |
|
1073
Labcorp
LH
$26.2B
| $42.8M | ﹤0.01% |
177,001
-1,798
| -1% | -$453K |
|
1074
Synchrony
SYF
$26.1B
| $42.7M | ﹤0.01% |
874,097
-356
| -0% | -$17.3K |
|
|
IMGO
1075
DELISTED
Imago BioSciences, Inc. Common stock
IMGO
| $42.7M | ﹤0.01% |
+2,203,604
| New | +$47.3M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.